BioSpace News Archive

Cerenis Therapeutics (FR0012616852 – CEREN – PEA-PME eligible) (Paris:CEREN), an international biopharmaceutical company dedicated to the discovery and development of HDL-based innovative therapies for treating cardiovascular and metabolic diseases,

Phoenix Children’s Care Network (PCCN) is proud to announce it is partnering with Bright Health, and soon Phoenix Children’s facilities and providers will be covered in-network on Bright Health Individual and Family health plans in Maricopa County.

GNS Healthcare (GNS), a leading precision medicine company, presented results in metastatic colorectal cancer this week from their most recent collaboration with the Alliance for Clinical Trials in Oncology (Alliance) at the ESMO 2018 conference held in Munich.

Marapharm Ventures Inc. (CSE: MDM) (OTCQX: MRPHF) (FSE: 2M0) (“Marapharm” or the “Company”) is very pleased to announce to its shareholders, that further to its news release of October 17, 2018, its first facility has been granted the final approval to commence operations, from the State of Nevada.

BioWave Corp., a Health Technology company that delivers Smarter Pain Blocking Technology™ today announced that its patented technology is now in use at more than 80 U.S. Department of Veterans Affairs (VA) Medical Centers nationwide.

Purdue will support SpineThera’s clinical development program to evaluate sustained-release, injectable treatment options for pain in and near the spine

PinneyAssociates is pleased to welcome Judy Ashworth, M.D., as Chief Medical Officer and Bernie Simone as Vice President, Client Strategy and Rx-to-OTC Switch

Varian (NYSE: VAR) today announced it has been ranked first in seven categories, including probability of repurchase, overall manufacturer performance, overall system performance and overall service performance in the ServiceTrak Imaging 2018 report on radiation oncology accelerator manufacturers published by IMV Medical Information Division.

Leading Seed-to-Sale Cannabis Software Firm to Service the World’s Largest Cannabis Entertainment Complex, Which Will Open its Doors on November 1st, 2018

The National Comprehensive Cancer Network’s Oncology Research Program received a grant to investigate effectiveness of trifluridine and tipiracil for treatment of people with colorectal, gastric, and other cancers